Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3811 AL 3825

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Kumar S, Reddy PH.

Biochim Biophys Acta. 2016 Sep;1862(9):1617-27. doi: 10.1016/j.bbadis.2016.06.001. Epub 2016 Jun 2.

[Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians]

Trombella S, Assal F, Zekry D, Gold G, Giannakopoulos P, Garibotto V, Démonet JF, Frisoni GB.

Rev Med Suisse. 2016 Apr 20;12(515):795-8.

Alterations in Glucose Metabolism in Alzheimer's Disease

Calsolaro V, Edison P.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):31-39. doi: 10.2174/1872214810666160615102809.

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife

Racine AM, Koscik RL, Berman SE, Nicholas CR, Clark LR, Okonkwo OC, Rowley HA, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Gleason CE, Carlsson CM, Johnson SC.

Brain. 2016 Aug;139(Pt 8):2261-74. doi: 10.1093/brain/aww142. Epub 2016 Jun 20.

A new biomarker classification system for AD, independent of cognition: Agnosticism is a start

Murray AD.

Neurology. 2016 Aug 2;87(5):456-7. doi: 10.1212/WNL.0000000000002931. Epub 2016 Jul 1.

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B.

Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.

Retinal nerve fibre layer thickness changes in Alzheimer's disease: Results from a 12-month prospective case series

Trebbastoni A, D'Antonio F, Bruscolini A, Marcelli M, Cecere M, Campanelli A, Imbriano L, de Lena C, Gharbiya M.

Neurosci Lett. 2016 Aug 26;629:165-170. doi: 10.1016/j.neulet.2016.07.006. Epub 2016 Jul 6.

The Need for Early Detection and Treatment in Alzheimer's Disease

EBioMedicine. 2016 Jul;9:1-2. doi: 10.1016/j.ebiom.2016.07.001. Epub 2016 Jul 5.

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

Chiasserini D, Biscetti L, Farotti L, Eusebi P, Salvadori N, Lisetti V, Baschieri F, Chipi E, Frattini G, Stoops E, Vanderstichele H, Calabresi P, Parnetti L.

J Alzheimers Dis. 2016 Jul 22;54(1):55-67. doi: 10.3233/JAD-160298.

A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease

Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ.

J Alzheimers Dis. 2016 Jul 22;54(1):223-32. doi: 10.3233/JAD-160544.

Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data

Pagani M, Giuliani A, Öberg J, Chincarini A, Morbelli S, Brugnolo A, Arnaldi D, Picco A, Bauckneht M, Buschiazzo A, Sambuceti G, Nobili F.

Neuroimage. 2016 Nov 1;141:282-290. doi: 10.1016/j.neuroimage.2016.07.043. Epub 2016 Jul 22.

Alzheimer's disease: presence and role of microRNAs

Basavaraju M, de Lencastre A.

Biomol Concepts. 2016 Aug 1;7(4):241-52. doi: 10.1515/bmc-2016-0014.

Applied multimodal diagnostics in a case of presenile dementia

Schönecker S, Brendel M, Huber M, Vollmar C, Huppertz HJ, Teipel S, Okamura N, Levin J, Rominger A, Danek A.

BMC Neurol. 2016 Aug 9;16:131. doi: 10.1186/s12883-016-0647-7.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z.

Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias